855 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Novo Nordisk settles Victoza patent dispute with Teva https://seekingalpha.com/news/3443643-novo-nordisk-settles-victoza-patent-dispute-teva?source=feed_news_all Mar 18, 2019 - Novo Nordisk (NVO +0.7%) has settled its Victoza (liraglutide) patent infringement litigation with Teva Pharmaceutical Industries (TEVA -0.1%), allowing the latter launch a generic version the type 2
Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know http://www.zacks.com/stock/news/358797/teva-pharmaceutical-industries-ltd-teva-gains-but-lags-market-what-you-should-know?cid=CS-ZC-FT-358797 Mar 11, 2019 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $15.78, marking a +0.19% move from the previous day.
Why Teva Could Be The Next Bausch Health https://seekingalpha.com/article/4247052-teva-next-bausch-health?source=feed_sector_healthcare Mar 07, 2019 - Bausch Health's shareholder dilution overhang is noted.Why understanding Bausch Health made me comfortable with Teva.Why I think that Teva is a better investment and more undervalued than Bausch Healt
UBS sees 38% upside for Teva in permarket analyst action https://seekingalpha.com/news/3440662-ubs-sees-38-percent-upside-teva-permarket-analyst-action?source=feed_news_all Mar 07, 2019 - Chiasma (NASDAQ:CHMA) initiated with Overweight rating and $18 (208% upside) price target. Shares up 3% premarket.Mylan N.V. (NASDAQ:MYL) reiterated with Neutral rating and $31 (15% upside) price targ
Lilly's Emgality Gets FDA Priority Review for Cluster Headache http://www.zacks.com/stock/news/357965/lillys-emgality-gets-fda-priority-review-for-cluster-headache?cid=CS-ZC-FT-357965 Mar 06, 2019 - Eli Lilly's (LLY) supplemental biologics license application for its migraine drug, Emgality, wins a priority review from the FDA for treating episodic cluster headache in adults.
Why Teva Pharmaceutical Industries Stock Sank in February https://www.fool.com/investing/2019/03/06/why-teva-pharmaceutical-industries-stock-sank-in-f.aspx?source=iedfolrf0000001 Mar 06, 2019 - Teva's 2019 outlook sent investors packing last month.
Morgan Stanley cuts view on Teva in premarket analyst action https://seekingalpha.com/news/3440223-morgan-stanley-cuts-view-teva-premarket-analyst-action?source=feed_news_all Mar 06, 2019 - Voyager Therapeutics (NASDAQ:VYGR) initiated with Overweight rating and $27 (52% upside) price target at Cantor Fitzgerald.Mylan N.V. (NASDAQ:MYL) upgraded to Overweight with a $35 (28% upside) price
Alkermes' (ALKS) and Biogen's NDA for BIIB098 Accepted by FDA http://www.zacks.com/stock/news/356914/alkermes-alks-and-biogens-nda-for-biib098-accepted-by-fda?cid=CS-ZC-FT-356914 Feb 26, 2019 - The FDA accepts Alkermes (ALKS) and partner Biogen's NDA for diroximel fumarate and sets an action date in the fourth quarter of 2019.
Momenta (MNTA) Q4 Loss Narrower Than Expected, Revenues Beat http://www.zacks.com/stock/news/356858/momenta-mnta-q4-loss-narrower-than-expected-revenues-beat?cid=CS-ZC-FT-356858 Feb 25, 2019 - Momenta (MNTA) reported a narrower loss in Q4, while sales came ahead of expectations.
Goldentree Asset Management Lp Buys Caesars Entertainment Corp, Teva Pharmaceutical Industries, ... http://www.gurufocus.com/news/821378/goldentree-asset-management-lp-buys-caesars-entertainment-corp-teva-pharmaceutical-industries-international-game-technology-plc-sells-constellium-nv-encana-corp-pge-corp Feb 22, 2019 - Goldentree Asset Management Lp Buys Caesars Entertainment Corp, Teva Pharmaceutical Industries, International Game Technology PLC, Sells Constellium NV, Encana Corp, PG&E Corp, Stocks: BHC,HUN,LILAK,MIK,MTG,NRP,CZR,TEVA,IGT,QRTEA,FBC,G, release date:Feb 22, 2019

Pages: 1...4567891011121314...86

<<<Page 9>